The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

Mortality Rates among Carriers of Ataxia-Telangiectasia Mutant Alleles

Yun Su, MD, MPH; and Michael Swift, MD
[+] Article, Author, and Disclosure Information

Copyright ©2004 by the American College of Physicians

Ann Intern Med. 2000;133(10):770-778. doi:10.7326/0003-4819-133-10-200011210-00009
Text Size: A A A

Background: Mutations at the ataxia-telangiectasia locus cause a distinctive autosomal recessive syndrome in homozygotes and predispose heterozygotes to cancer and ischemic heart disease.

Objective: To examine mortality rates among persons carrying a mutated ataxia-telangiectasia gene.

Design: Retrospective cohort study.

Setting: The United States and Canada.

Participants: 405 grandparents of patients with ataxia-telangiectasia.

Measurements: Ages at death and risk for death (from all causes, cancer, ischemic heart disease, and other causes) among carriers and noncarriers of ataxia-telangiectasia mutations.

Results: Compared with noncarriers, carriers of a mutated ataxia-telangiectasia allele had a significantly increased risk for death at 20 through 79 years of age (relative risk, 1.9 [95% CI, 1.3 to 2.8]) (P < 0.001). On average, carriers died 7 to 8 years earlier than noncarriers. Cancer caused most of the excess deaths, and ischemic heart disease caused the remainder. Among carriers, relative risk for death from cancer and ischemic heart disease before 80 years of age was 2.6 (CI, 1.4 to 4.7; P = 0.002) and 2.0 (CI, 1.0 to 4.0; P = 0.062), respectively. Compared with noncarriers, carriers who died of cancer were a mean of 4 years younger (P > 0.2) and carriers who died of ischemic heart disease were a mean of 11 years younger (P = 0.006).

Conclusion: Carriers of mutations at the ataxia-telangiectasia locus, who make up 1.4% to 2% of the general population, have a higher mortality rate and an earlier age at death from cancer and ischemic heart disease than noncarriers.


Grahic Jump Location
Kaplan–Meier curves for the cumulative risk for death from 20 through 79 years of age in grandparents of patients with ataxia-telangiectasia, according to carrier status.A.PB.PC.PD.PP

Risk for death from all causes (67 of 204 carriers, 43 of 201 noncarriers) (  = 0.006). Risk for death from cancer (35 of 204 carriers, 16 of 201 noncarriers) (  = 0.003). Risk for death from ischemic heart disease (19 of 204 carriers, 13 of 201 noncarriers) (  = 0.175). Risk for death from other causes (13 of 204 carriers, 14 of 201 noncarriers) (  > 0.2). Solid lines represent carriers, and dotted lines represent noncarriers. All  values were determined by using the two-sided log-rank test.

Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Death Rates of People Who Carry the Gene for Ataxia-Telangiectasia

Copyright ©2004 by the American College of Physicians


Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.